Repligen (RGEN) Interest Expenses (2011 - 2026)
Repligen (RGEN) posted quarterly Interest Expenses of $37.1 million for Q2 2026, down 5.67% year-over-year from $39.3 million in Q2 2025, and little changed quarter-over-quarter from $37.2 million in Q1 2026.
Repligen (RGEN) Interest Expenses (2011 - 2026) Analysis & Trends
Repligen (RGEN) has reported Interest Expenses for 16 consecutive years, with $37.1 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Interest Expenses fell 5.67% year-over-year to $37.1 million; the TTM figure through Jun 2026 stood at $37.1 million (down 5.67% YoY), while the FY2025 annual figure was $34.9 million, up 46.51% from the prior year.
- Interest Expenses steadied at $37.1 million in Q2 2026 per RGEN's latest filing, from $37.2 million in the prior quarter.
- Across five years, Interest Expenses topped out at $233.1 million in Q2 2024 and bottomed at -$1.0 million in Q4 2022.
- Historically, Interest Expenses has averaged $88.2 million across 5 years, with a median of $39.3 million in 2025.
- Annual changes were most pronounced in 2022 — Interest Expenses sank 317.49% — and 2024, when it soared 2240.06%.
- Repligen's Interest Expenses stood at -$1.0 million in 2022, then soared by 131.98% to $322000.0 in 2023, then jumped by 2240.06% to $7.5 million in 2024, then tumbled by 38.25% to $4.7 million in 2025, then surged by 697.42% to $37.1 million in 2026.
- Business Quant data shows RGEN's Interest Expenses at $37.1 million in Q2 2026, $37.2 million in Q1 2026, and $4.7 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | - |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 132.00 Mn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | 53.00 Mn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | - |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | - |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 2.60 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | - |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 20.90 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | - |
| 10 | Repligen | 10.25 Bn | 9.24 Bn | 110.04 Mn | 5.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 37.10 Mn |
| Jun 30, 2026 | 37.10 Mn |
| Mar 31, 2026 | 37.19 Mn |
| Mar 31, 2026 | 37.19 Mn |
| Dec 31, 2025 | 4.65 Mn |
| Dec 31, 2025 | 4.65 Mn |
| Sep 30, 2025 | 39.21 Mn |
| Sep 30, 2025 | 39.21 Mn |
| Jun 30, 2025 | 39.33 Mn |
| Jun 30, 2025 | 39.33 Mn |
| Mar 31, 2025 | 36.98 Mn |
| Mar 31, 2025 | 36.98 Mn |
| Dec 31, 2024 | 7.54 Mn |
| Dec 31, 2024 | 7.54 Mn |
| Sep 30, 2024 | 33.86 Mn |
| Sep 30, 2024 | 33.86 Mn |
| Jun 30, 2024 | 233.10 Mn |
| Jun 30, 2024 | 233.10 Mn |
| Mar 31, 2024 | 232.93 Mn |
| Mar 31, 2024 | 232.93 Mn |